TLR4 and NKT cell synergy in immunotherapy against visceral leishmaniasis - Wikidata - wikimedia - TriplyDB

TLR4 and NKT cell synergy in immunotherapy against visceral leishmaniasis

TLR4 and NKT cell synergy in immunotherapy against visceral leishmaniasis

http://www.wikidata.org/entity/Q27346402

about

Effects of Invariant NKT Cells on Parasite Infections and Hygiene Hypothesis Innate immunity against Leishmania infections Regulation of immunity during visceral Leishmania infection Sphingolipid degradation in Leishmania (Leishmania) amazonensis Immunotherapy and Immunochemotherapy in Visceral Leishmaniasis: Promising Treatments for this Neglected Disease.Leishmania infantum Exoproducts Inhibit Human Invariant NKT Cell Expansion and Activation Deception and manipulation: the arms of leishmania, a successful parasite Crucial and diverse role of the interleukin-33/ST2 axis in infectious diseases.Successful Therapy of Murine Visceral Leishmaniasis with Astrakurkurone, a Triterpene Isolated from the Mushroom Astraeus hygrometricus, Involves the Induction of Protective Cell-Mediated Immunity and TLR9 Mechanisms of immune evasion in leishmaniasis Regulatory actions of Toll-like receptor 2 (TLR2) and TLR4 in Leishmania donovani infection in the liver.Co-administration of α-GalCer analog and TLR4 agonist induces robust CD8(+) T-cell responses to PyCS protein and WT-1 antigen and activates memory-like effector NKT cells Immune responses against protozoan parasites: a focus on the emerging role of Nod-like receptors.Local Delivery of the Toll-Like Receptor 9 Ligand CpG Downregulates Host Immune and Inflammatory Responses, Ameliorating Established Leishmania (Viannia) panamensis Chronic Infection.SLA-PGN-primed dendritic cell-based vaccination induces Th17-mediated protective immunity against experimental visceral leishmaniasis: a crucial role of PKCβ.Translating immune cell cross-talk into a treatment opportunity for visceral leishmaniasis.

P2860

Q26738653-7450FBAE-1FAE-456E-8898-36C2A5989783 Q27010187-570F178E-E3B1-4787-845D-15794077457D Q28066034-F55F3624-7CD3-4F0D-BDEB-6BC499AC14CE Q28484461-559A2BDE-BC7D-4C92-9DB4-389476F97D56 Q33749424-E977AEA6-F614-4927-B98E-5D0C0786FBFC Q33810033-2EC4B488-4FCB-428A-BF92-13265B9AF3EA Q34369161-C31C68CE-8CA2-4F2B-9A41-D14117D09DA0 Q35439783-E43FE034-7DEE-4328-9EBD-0429C62A57B4 Q36888107-39827366-B147-4523-9681-FEFE8DE05CE5 Q36969164-454D5E11-EC86-45BA-AB68-8F1BCD17F266 Q36970905-656465D7-D549-4A41-B75F-4BDDFC44B96B Q37083610-90248A47-94A5-4F89-891C-C401766DA87A Q38794791-C6EAFE7C-9EC4-48E4-B100-7188CA545976 Q40385380-0BD0DEF6-5581-44B6-9D6F-D62BA78EAF85 Q50855811-6B528675-1C42-43CA-A052-8DB2C8B12A67 Q53088160-B06003D1-8B18-4A7A-B672-7A6EA6676066

P2860

TLR4 and NKT cell synergy in immunotherapy against visceral leishmaniasis

http://www.wikidata.org/entity/Q27346402

description

2012 nî lūn-bûn

@nan

2012 թուականին հրատարակուած գիտական յօդուած

@hyw

2012 թվականին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

TLR4 and NKT cell synergy in immunotherapy against visceral leishmaniasis

@ast

TLR4 and NKT cell synergy in immunotherapy against visceral leishmaniasis

@en

TLR4 and NKT cell synergy in immunotherapy against visceral leishmaniasis

@nl

type

label

TLR4 and NKT cell synergy in immunotherapy against visceral leishmaniasis

@ast

TLR4 and NKT cell synergy in immunotherapy against visceral leishmaniasis

@en

TLR4 and NKT cell synergy in immunotherapy against visceral leishmaniasis

@nl

prefLabel

TLR4 and NKT cell synergy in immunotherapy against visceral leishmaniasis

@ast

TLR4 and NKT cell synergy in immunotherapy against visceral leishmaniasis

@en

TLR4 and NKT cell synergy in immunotherapy against visceral leishmaniasis

@nl

P1433

Q27346402-6009C992-02DE-46E7-ADAA-B3D7133E7CE4

P1476

Q27346402-81604973-7D5D-4FDA-A739-E1343E8B2E49

P2093

Q27346402-8DF9D01A-26DF-4875-80CA-87841F7D7A7D

Q27346402-B218AAA0-3C5D-440E-B6D4-5ED56D28823C

Q27346402-C95363B5-971D-4656-8967-B98FA0CA589F

Q27346402-F785E088-5154-40C9-B3B4-6BDBAD4323F6

P2860

Q27346402-05D4623C-1E9E-4B1E-ABAA-04359517F4FD

Q27346402-1471BF4E-B385-41AD-9BE0-4C6F311D5033

Q27346402-1564F8B1-8D2B-477F-8BAF-5D3215EBEC7B

Q27346402-17157FB8-08B1-492B-B5A5-C671E2E593FB

Q27346402-19073E54-ADA6-49C4-8D5F-264F7D58070E

Q27346402-19650EAF-65F2-4157-975D-EA33E9401589

Q27346402-1CCDCAC3-6983-4A8E-8B51-DC26AF5431B9

Q27346402-21DB9695-0BC8-4A30-8F79-26D8BDC2DEA7

Q27346402-26523BBC-02EB-474C-82FC-7C2569ED2D0A

Q27346402-2EC37E58-96C0-45E7-A5FC-BF5A3A970346

P304

Q27346402-3F493D10-41BE-4F37-8837-162D275B4A48

P31

Q27346402-0A086C03-A1D9-42E8-8FB2-2C7DD41ABA05

P3181

Q27346402-280EE0B0-0903-4299-B785-C0A15E53D668

P356

Q27346402-2D05032F-F5D0-4CCE-B584-D9CD4B585893

P407

Q27346402-4E726A22-653A-45D6-A36C-8B28AAE908BE

P433

Q27346402-2BDA6679-E0F8-421D-917A-95A93EB9601E

P478

Q27346402-F197FD45-D468-401E-9E0C-A0F0CB77C5C4

P577

Q27346402-C4EE7CA5-8048-4754-BE07-CBB37A590850

P5875

Q27346402-FCCDC8A5-97B5-4548-A186-C20709FDA4A2

P698

Q27346402-873C54AE-14A8-42C5-AB93-7FCD11A2B4CF

P921

Q27346402-21C892BC-B952-4A37-B556-84893FB21A64

Q27346402-3B68A526-894D-49BC-A105-8AD9472E2FA6

Q27346402-3C1B345D-A014-408D-AD56-6FC51D5CAD81

P932

Q27346402-1B0353A9-FFF5-4656-BC5F-A64856FE1647

P3181

P356

JOURNAL.PPAT.1002646

P1433

P1476

TLR4 and NKT cell synergy in immunotherapy against visceral leishmaniasis

@en

P2093

Joydeep Paul

http://www.w3.org/2001/XMLSchema#string

Siddhartha Kumar Bhaumik

http://www.w3.org/2001/XMLSchema#string

Subir Karmakar

http://www.w3.org/2001/XMLSchema#string

Tripti De

http://www.w3.org/2001/XMLSchema#string

P2860

IL-23 modulates CD56+/CD3- NK cell and CD56+/CD3+ NK-like T cell function differentially from IL-12

Activation of invariant NKT cells exacerbates experimental visceral leishmaniasis

Innate immune recognition: mechanisms and pathways

Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic

The biology of NKT cells

Toll-like receptors: critical proteins linking innate and acquired immunity

Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria.

Leishmania species: models of intracellular parasitism.

Clinical and experimental advances in treatment of visceral leishmaniasis.

Glycosphingolipid-blotting: an immunological detection procedure after separation by thin layer chromatography.

P304

e1002646

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4141417

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PPAT.1002646

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224285165

http://www.w3.org/2001/XMLSchema#string

P698

22511870

http://www.w3.org/2001/XMLSchema#string

P921

visceral leishmaniasis

Toll-like receptor

P932

3325212

http://www.w3.org/2001/XMLSchema#string